A detailed history of Sicart Associates LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Sicart Associates LLC holds 146,303 shares of GH stock, worth $5.1 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares
146,303
Previous 145,983 0.22%
Holding current value
$5.1 Million
Previous $4.22 Million 20.43%
% of portfolio
1.23%
Previous 1.69%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$22.3 - $36.29 $7,136 - $11,612
320 Added 0.22%
146,303 $3.35 Million
Q2 2024

Aug 02, 2024

SELL
$16.07 - $31.84 $9,786 - $19,390
-609 Reduced 0.42%
145,983 $4.22 Million
Q1 2024

May 02, 2024

BUY
$17.13 - $26.91 $918,836 - $1.44 Million
53,639 Added 57.71%
146,592 $3.02 Million
Q4 2023

Jan 19, 2024

SELL
$21.58 - $29.5 $64,135 - $87,674
-2,972 Reduced 3.1%
92,953 $2.51 Million
Q3 2023

Oct 25, 2023

BUY
$25.8 - $39.97 $76,239 - $118,111
2,955 Added 3.18%
95,925 $2.84 Million
Q2 2023

Jul 28, 2023

BUY
$20.94 - $38.01 $63,867 - $115,930
3,050 Added 3.39%
92,970 $3.33 Million
Q1 2023

May 09, 2023

SELL
$22.92 - $33.76 $184,964 - $272,443
-8,070 Reduced 8.24%
89,920 $2.11 Million
Q4 2022

Jan 27, 2023

SELL
$25.44 - $59.78 $978,651 - $2.3 Million
-38,469 Reduced 28.19%
97,990 $0
Q3 2022

Nov 01, 2022

SELL
$43.66 - $61.0 $62,433 - $87,230
-1,430 Reduced 1.04%
136,459 $7.35 Million
Q2 2022

Aug 05, 2022

BUY
$28.82 - $77.35 $121,706 - $326,649
4,223 Added 3.16%
137,889 $5.56 Million
Q1 2022

May 06, 2022

BUY
$48.25 - $100.49 $4.43 Million - $9.22 Million
91,783 Added 219.14%
133,666 $8.85 Million
Q4 2021

Jan 31, 2022

BUY
$88.71 - $120.43 $3,637 - $4,937
41 Added 0.1%
41,883 $4.2 Million
Q3 2021

Oct 22, 2021

BUY
$98.77 - $132.17 $130,573 - $174,728
1,322 Added 3.26%
41,842 $5.23 Million
Q2 2021

Jul 23, 2021

BUY
$109.77 - $165.68 $4.45 Million - $6.71 Million
40,520 New
40,520 $5.03 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.56B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Sicart Associates LLC Portfolio

Follow Sicart Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sicart Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sicart Associates LLC with notifications on news.